Pemphigus vulgaris as an immune-related adverse event in recurrent metastatic esophageal squamous cell carcinoma treated with ipilimumab plus nivolumab: a case report and literature review

Ipilimumab plus nivolumab therapy is approved for patients with unresectable advanced esophageal squamous cell carcinoma (ESCC). Although a combination of immune checkpoint inhibitors (ICIs), compared to conventional chemotherapy, can improve overall survival in patients with advanced ESCC, this inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Hajime, Shionoya, Aika, Arihara, Yohei, Hayasaka, Naotaka, Kubo, Tomohiro, Usami, Makoto, Sugita, Shintaro, Uhara, Hisashi, Takada, Kohichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518453/
https://www.ncbi.nlm.nih.gov/pubmed/37753079
http://dx.doi.org/10.3389/fimmu.2023.1259071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518453/
https://www.ncbi.nlm.nih.gov/pubmed/37753079
http://dx.doi.org/10.3389/fimmu.2023.1259071

Ejemplares similares